Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0011854 (
type 1 diabetes
)
20,749
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Autism spectrum disorder
(
ASD
) is a set of complex neurodevelopmental disorders. Recent studies reported that children with
ASD
have altered gut microbiota profiles compared with typical development (TD) children. However, few studies on gut bacteria of children with
ASD
have been conducted in China. Here, in order to elucidate changes of fecal microbiota in children with
ASD
, 16S rRNA sequencing was conducted and the 16S rRNA (V3-V4) gene tags were amplified. We investigated differences in fecal microbiota between 35 children with
ASD
and 6 TD children. At the phylum level, the fecal microbiota of
ASD
group indicated a significant increase of the Bacteroidetes/Firmicutes ratio. At the genus level, we found that the relative abundance of Sutterella, Odoribacter and Butyricimonas was much more abundant in the
ASD
group whereas the abundance of Veillonella and Streptococcus was decreased significantly compared to the control group. Functional analysis demonstrated that butyrate and lactate producers were less abundant in the
ASD
group. In addition, we downloaded the association data set of microbe-disease from human microbe-disease association database and constructed a human disease network including
ASD
using our gut microbiome results. In this microbe-disease network based on microbe similarity of diseases, we found that
ASD
is positively correlated with periodontal, negatively related to
type 1 diabetes
. Therefore, these results suggest that microbe-based disease analysis is able to predict novel connection between
ASD
and other diseases and may play a role in revealing the pathogenesis of
ASD
.
...
PMID:Analysis of gut microbiota profiles and microbe-disease associations in children with autism spectrum disorders in China. 3022 82